Management of small hepatocellular carcinoma

Acta Gastro-Enterologica Belgica

Volumn 69, Issue 2, 2006, Pages 230-235

  Leoni, S ^a   Piscaglia, F ^a   Righini, R ^a   Bolondi, L ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CHRONIC LIVER DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER NODULE; LIVER RESECTION; LIVER TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; RADIODIAGNOSIS; SCREENING; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL; ULTRASONOGRAPHY;

EID: 33747621853     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (56)

1. BURREL M., LLOVET J., AYUSO C., IGLESIAS C., SALA M., MIQUEL R., CARALT T., AYUSO J.R., SOLE M., SANCHEZ M., BRU C., BRUIX J.; BARCELONA CLINIC LIVER CANCER GROUP. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology, 2003, 38: 1034-1042.
2. TERADA T., TERASAKI S., NAKANUMA Y. A clinicopathologic study of adenomatous hyperplasia of the liver in 209 consecutive cirrhotic livers examined by autopsy. Cancer, 1993, 72: 1151-1156.
3. TERADA T., UEDA K., NAKANUMA Y. Histopathological and morphometric analysis of atypical adenomatous hyperplasia of human cirrhotic livers. Virchows Arch. A Pathol. Anat. Histopathol., 1993, 422: 381-388.
4. TAKAYAMA T., MAKUUCHI M., HIROHASHI S., SAKAMOTO M., OKAZAKI N., TAKAYASU K., KOSUGE T., MOTOO Y., YAMAZAKI S., HASEGAWA H. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet, 1990, 336: 1150-1153.
5. BORZIO M., FARGION S., BORZIO F., FRACANZANI A., CROCE A., STROFFOLINI T., OLDANI S., COTICHINI R., RONCALLI M. Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. J. Hepatol., 2003, 39: 209-214.
6. BOLONDI L., GRAMANTIERI L., CHIECO P., MELCHIORRI C., TRERÈ D., STECCA B., DERENZINI M., BARBARA L. Enzymatic cytochemistry, DNA ploidy and AgNOR quantitation in hepatocellular nodules of uncertain malignant potential in liver cirrhosis. Dig. Dis. Sci., 1996, 41: 800-808.
7. TERASAKY S., KANEDO S., KOBAYASHI K., NONOMURA A., NAKANUMA Y. Histological features predicting malignant transformation of non-malignant hepatocellular nodules: a prospective study. Gastroenterology, 1998, 115: 1216-1222.
8. BOLONDI L., SOFIA S., SIRINGO S., GAIANI S., CASALI A., ZIRONI G., PISCAGLIA F., GRAMANTIERI L., ZANETTI M., SHERMAN M. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut, 2001, 48: 251-259.
9. SAKAMOTO M., HIROHASHI S. Natural history and prognosis of adenomatous hyperplasia and early hepatocellular carcinoma: multi-institutional analysis of 53 nodules followed up for more than 6 months and 142 patients with single early hepatocellular carcinoma treated by surgical resection or percutaneous ethanol injection. Jpn. J. Clin. Oncol., 1998, 28: 604-608.
10. NAKASHIMA Y., NAKASHIMA O., HSIA C., KOJIRO M., TABOR E. Vascularization of small hepatocellular carcinoma: correlation with differentiation. Liver, 1999, 19: 12-18.
11. BRUIX J., SHERMAN M., LLOVET J., BEAUGRAND M., LENCIONI R., BURROUGHS A., CHRISTENSEN E., PAGLIARO L., COLOMBO M., RODES J., EASL PANEL OF EXPERTS ON HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J. Hepatol., 2001, 35: 421-430.
12. TAYLOR K.J.W., RAMOS I., MORSE S.S., FORTUNE K., HAMMERS L., TAYLOR C.R. Focal liver masses: differential diagnosis with pulsed Doppler. Radiology, 1987, 164: 643-647.
13. TAYLOR K.J.W., RAMOS I., CARTER D., MORSE S.S., SNOWER D., FORTUNE K. Correlation of Doppler US tumor signals with neovascular morphological features. Radiology, 1988, 166: 57-62.
14. RUBIN J.M., BUDE R.O., CARSON P.L., BREE R.L., ADLER R.S. Power Dopler US: a potentially useful alternative to mean frequency-based color Doppler sonography. Radiology, 1994, 190: 853-856.
15. IMAMURA M., SHIRATORI Y., SHIINA S., SATO S., OBI S., OKUDAIRA T., TERATANI T., KATO N., AKAHANE M., OHTOMO K., MINAMI M., OMATA M. Power Doppler sonography for hepatocellular carcinoma: factors affecting the power Doppler signals of the tumors. Liver, 1998, 18: 427-433.
16. SCHLIEF R. Development of echo-enhancing agents. Clin. Radiol., 1996, 51 (suppl.): 57.
17. BLOMLEY M.J.K., COSGROVE D.O. Microbubble echo-enhancers: a new direction for ultrasound? Lancet 1997, 349: 1855-1856.
18. KIM A.Y., CHOI B.I., KIM T.K., HAN J.K., YUN E.J., LEE K.Y., HAN M.C. Hepatocellular carcinoma: power Doppler US with a contrast agent: preliminary results. Radiology, 1998, 209: 135-140.
19. GAIANI S., CELLI N., PISCAGLIA F., CECILIONI L., LOSINNO F., GIANGREGORIO F., MANCINI M., PINI P., FORNARI F., BOLONDI L. Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J. Hepatol., 2004, 41: 421-426.
20. LEE K.H.Y., O'MALLEY M.E., HAIDER M.A., HANBIDGE A. Triple-phase MDCT of hepatocellular carcinoma. AJR, 2004, 182: 643-649.
21. HAYASHI M., MATSUI O., UEDA K., KAWAMORI Y., GABATA T., KADOYA M. Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. Radiology, 2002, 225: 143-149.
22. KUDO M. Imaging diagnosis of hepatocellular carcinoma and pre-malignant/borderline lesions. Semin. Liver Dis., 1999, 19: 297-309.
23. BOLONDI L., GAIANI S., CELLI N., GOLFIERI R., GRIGIONI F.R., LEONI S., VENTURI A.M., PISCAGLIA F. Characterization of small nodules in liver cirrhosis by assessment of vascularity. The problem of hypovascular HCC. Hepatology, 2005, 42: 27-34.
24. OHASHI I., HANAFUSA K., YOSHIDA T. Small hepatocellular carcinoma: two-phase dynamic incremental CT in detection and evaluation. Radiology, 1993, 189: 851-855.
25. BARON R., OLIVER J. III, DODD G. III, NALESNIK M., HOLBERT B., CARR B. Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT. Radiology, 1996, 199: 505-511.
26. OLIVER J.H. III, BARON R.L. Helical biphasic contrast-enhanced CT of the liver: technique, indications, interpretation and pitfalls. Radiology, 1996, 201: 1-14.
27. MILLER W.J., BARON R.L., DODD G.D. III, FEDERLE M.P. Malignancies in patients with cirrhosis: CT sensitivity and specificity in, 200 consecutive transplant patients. Radiology, 1994, 193: 645-650.
28. KIM H.J., KIM A.Y., KIM T.K., BYUN J.H., WON H.J., KIM K.W., SHIN Y.M., KIM P.N., HA H.K., LEE M.G. Transient hepatic attenuation differences in focal hepatic lesions: dynamic CT features. AJR, 2005, 184: 83-90.
29. TAOULI B., LOSADA M., HOLAND A., KRINSKY G. Magnetic resonance imaging of hepatocellular carcinoma. Gastroenterology, 2004, 127: S144-152.
30. SHAPIRO R.S., KATZ R., MENDELSON D.S., HALTON K.P., SCHWARTZ M.E., MILLER C.M. Detection of hepatocellular carcinoma in cirrhotic patients: sensitivity of CT and ultrasonography. J. Ultrasound Med., 1996, 15: 497-502.
31. YAMASHITA Y., MITSUZAKI K., YI T. et al. Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology. 1996, 200: 79-84.
32. TANG Y., YAMASHITA Y., ARAKAWA A., NAMIMOTO T., MITSUZAKI K., ABE Y., KATAHIRA K., TAKAHASHI M. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumox-ides-enhanced MR imaging. AJR, 1999, 172: 1547-1554.
33. KRINSKY G., LEE V., THEISE N., WEINREB J., ROFSKY N., DIFLO T., TEPERMAN L.W. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Radiology, 2001, 219: 445-454.
34. BHARTIA B., WARD J., GUTHRIE J., ROBINSON P. Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue. AJR, 2003, 180: 577-584.
35. EARLS J.P., THIESE N.D., WEINREB J.C. DECORATO D.R., KRINSKY G.A., ROFSKY N.M., MIZRACHI H., TEPERMAN L.W. Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation. Radiology, 1996, 201: 207-214.
36. WARD J., GUTHRIE J.A., SCOTT D.J., ATCHLEY J., WILSON D., DAVIES M.H., WYATT J.L., ROBINSON P.J. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis. Radiology, 2000, 216: 154-162.
37. TAKETA K. α-Fetoprotein: reevaluation in hepatology. Hepatology, 1990, 12: 1420-1432.
38. PARADIS V., DEGOS F., DARGÈRE D., PHAM N., BELGHITI J., DEGOTT C., JANEAU J.L., BEZEAUD A., DELFORGE D., CUBIZOLLES M., LAURENDEAU I., BEDOSSA P. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology, 2005, 41: 40-47.
39. LLOVET J.M., BRUIX J., GORES G.J. Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy. Hepatology, 2000, 31: 1019-1021.
40. LCSG. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer, 1994, 74: 2772-2780.
41. BISMUTH H., MAJNO P.E. Hepatobiliary surgery. J. Hepatol., 2000, 32: 208-224.
42. ARII S., YAMAOKA Y., FUTUGAWA S., INOUE K., KOBAYASHI K., KOJIRO M. et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. Hepatology, 2000, 32: 1224-1229.
43. LIVRAGHI T., GIORGIO A., MARIN G., SALMI A., DE SIO I., BOLONDI L., POMPILI M., BRUNELLO F., LAZZARONI S., TORZILLI G. et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology, 1995, 197: 101-108.
44. SHIINA S., TAGAWA K., UNUMA T., TAKANASHI R., YOSHIURA K., KOMATSU Y., HATA Y., NIWA Y., SHIRATORI Y., TERANO A. et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: a histopathologic study. Cancer, 1991, 68: 1524-1530.
45. EBARA M., OTHO M., SUGIURA N., OKUDA K., KONDO F., KONDO K. Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma: study of 95 patients. J. Gastroenterol. Hepatol., 1990, 616-626.
46. LIVRAGHI T., NAHUM GOLDBERG S., LAZZARONI S., MELONI F., SOLBIATI L., SCOTT GAZELLE G. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology, 1999, 210: 655-661.
47. LENCIONI RSNA, 1999.
48. SHIINA S., TERATANI T., OBI S., SATO S., TATEISHI R., FUJISHIMA T., ISHIKAWA T., KOIKE Y., YOSHIDA H., KAWABE T., OMATA M. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology, 2005, 129: 122-130.
49. LU M.-D., XU H.-X., XIE X.-Y., YIN X.-Y., CHEN J.-W., KUANG M., XU Z.-F., LIU G.-J., ZHENG Y.-L. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol, 2005, 40: 1054-1060.
50. LIN S.-M., LIN C.-J., LIN C.-C., HSU C.-W., CHEN Y.-C. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut, 2005, 54: 1151-1156.
51. HENRION J. Surveillance for hepatocellular carcinoma... A hotly debated issue. Acta Gastroenterol. Belg., 2004, 67: 255-264.
52. VAN VLIERBERGHE H., BORBATH I., DELWAIDE J., HENRION J., MICHIELSEN P., VERSLYPE CH. et al. BASL guidelines for the surveillance, diagnosis and treatment of hepatocellular carcinoma. Acta Gastroenterol. Belg., 2004, 67: 14-25.
53. BOLONDI L. Screening of hepatocellular carcinoma in cirrhosis. J. Hepatol., 2003, 39: 1076-1084.
54. SOLMI L., PRIMERANO A.M., GANDOLFI L. Ultrasound follow-up of patients at risk for hepatocellular carcinoma: results of a prospective study on 360 cases. Am. J. Gastroenterol., 1996, 91: 1189-1194.
55. YUEN M.F., CHENG C.C., LAUDER I.J., LAM S.K., OOI C.G., LAI C.L. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology, 2000, 31: 330-335.
56. TREVISANI F., DE NOTARIIS S., RAPACCINI G., FARINATI F., BENVEGNU L., ZOLI M., GRAZI G.L., BERNARDI M. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on Cancer stage and patients survival (Italian experience). Am. J. Gastroenterol., 2002, 97: 734-744.